Marye Anne Fox's Net Worth

$6.55 Million

Estimate Recalculated Nov 8, 2024 04:31PM EST

Who is Marye Anne Fox?

Marye Anne Fox has an estimated net worth of $6.55 Million. This is based on reported shares across multiple companies, which include GCP Applied Technologies Inc., Bridgepoint Education Inc, BOSTON SCIENTIFIC CORP, W R GRACE & CO, PHARMACEUTICAL PRODUCT DEVELOPMENT INC, and RED HAT INC.

SEC CIK

Marye Anne Fox's CIK is 0001180603

Past Insider Trading and Trends

2006 was Marye Anne Fox's most active year for acquiring shares with 12 total transactions. Marye Anne Fox's most active month to acquire stocks was the month of April. 2015 was Marye Anne Fox's most active year for disposing of shares, totalling 17 transactions. Marye Anne Fox's most active month to dispose stocks was the month of July. 2012 saw Marye Anne Fox paying a total of $387,050.00 for 33,696 shares, this is the most they've acquired in one year. In 2015 Marye Anne Fox cashed out on 29,242 shares for a total of $1,523,667.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

GCP Applied Technologies Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+8.87%
4.46K
—
—
54.73K
May 5
Form 4
∞
50.27K
—
—
50.27K
Feb 3
Form 3
—
0
—
—
0
No matching records found

Bridgepoint Education Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

BOSTON SCIENTIFIC CORP (BSX) Snapshot price: $81.6

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 11
Form 4
+219.38%
14.5K
—
—
21.11K
May 5
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
May 6
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Sep 28
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
May 8
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Dec 29
Form 4
—
0
—
—
0
Sep 29
Form 4
—
0
—
—
0
Jul 25
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Dec 30
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
May 10
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
May 11
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Dec 31
Form 4
+14.28%
457
$65.11
$29,756.80
3.66K
Oct 27
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
No matching records found

W R GRACE & CO No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2.12%
1.04K
—
—
50.27K
May 7
Form 4
-16.88%
-10.00K
$99.36
-$993,587.00
49.23K
Feb 11
Form 4
+1.85%
1.08K
—
—
59.23K
May 8
Form 4
+2.64%
1.5K
—
—
58.15K
Feb 27
Form 4
+2.36%
1.3K
—
—
56.65K
May 2
Form 4/A
+34.19%
14.1K
$3.45
$48,685.89
55.35K
Dec 3
Form 4
+34.19%
14.1K
$3.45
$48,685.89
55.35K
Dec 3
Form 4
+28.95%
9.26K
—
—
41.25K
Jan 2
No matching records found

PHARMACEUTICAL PRODUCT DEVELOPMENT INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 16
Form 4
+38.11%
1.99K
—
—
7.21K
Jan 3
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
Form 4
+65.32%
1.03K
—
—
2.61K
Jan 3
Form 4
—
0
—
—
0
May 18
Form 4
∞
1.58K
—
—
1.58K
Jan 3
Form 4
—
0
—
—
0
May 19
No matching records found